Identification of a high-risk immunogenic prostate cancer patient subset as candidates for T-cell engager immunotherapy and the introduction of a novel albumin-fused anti-CD3 × anti-PSMA bispecific design. / Glud, Eske N.; Rasmussen, Martin; Zhang, Yonghui et al.
In: British Journal of Cancer, Vol. 127, No. 12, 12.2022, p. 2186-2197.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Cost-Effectiveness Analysis of Stockholm 3 Testing Compared to PSA as the Primary Blood Test in the Prostate Cancer Diagnostic Pathway : A Decision Tree Approach. / Risør, Bettina Wulff; Tayyari Dehbarez, Nasrin; Fredsøe, Jacob Hesselvig et al.
In: Applied Health Economics and Health Policy, Vol. 20, No. 6, 11.2022, p. 867-880.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Recurrence rate after radical prostatectomy following primary staging of high-risk prostate cancer with 68Ga-PSMA PET/CT. / Klingenberg, Søren; Fredsøe, Jacob Hesselvig; Sørensen, Karina Dalsgaard et al.
In: Acta Oncologica, Vol. 61, No. 10, 11.2022, p. 1289-1294.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Circulating free testosterone and risk of aggressive prostate cancer : Prospective and Mendelian randomisation analyses in international consortia. / Watts, Eleanor L; Perez-Cornago, Aurora; Fensom, Georgina K et al.
In: International Journal of Cancer, Vol. 151, No. 7, 10.2022, p. 1033-1046.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
A genome-wide CRISPR-Cas9 knockout screen identifies novel PARP inhibitor resistance genes in prostate cancer. / Ipsen, Malene Blond; Sørensen, Ea Marie Givskov; Thomsen, Emil Aagaard et al.
In: Oncogene, Vol. 41, No. 37, 09.2022, p. 4271-4281.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Predicting Grade group 2 or higher cancer at prostate biopsy by 4Kscore in blood and uCaP microRNA model in urine. / Fredsøe, Jacob; Rasmussen, Martin; Tin, Amy L et al.
In: Scientific Reports, Vol. 12, 15193, 09.2022.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Rare Germline Variants Are Associated with Rapid Biochemical Recurrence After Radical Prostate Cancer Treatment : A Pan Prostate Cancer Group Study. / Burns, Daniel; Anokian, Ezequiel; Saunders, Edward J. et al.
In: European Urology, Vol. 82, No. 2, 08.2022, p. 201-211.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Ethical Principles in the Analysis of Prostate Cancer Diagnostics. / Ebbesen, Mette; Sørensen, Karina Dalsgaard; Pedersen, Bodil Ginnerup et al.
In: Cancer Investigation, Vol. 40, No. 9, 07.2022, p. 799-810.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Unsupervised detection of fragment length signatures of circulating tumor DNA using non-negative matrix factorization. / Renaud, Gabriel; Nørgaard, Maibritt; Lindberg, Johan et al.
In: eLife, Vol. 11, e71569, 07.2022.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Prostate Cancer Detection Rate of Manually Operated and Robot-assisted In-bore Magnetic Resonance Imaging Targeted Biopsy. / Sandahl, Mads; Sandahl, Kristian Juul; Marinovskij, Edvard et al.
In: European Urology Open Science, Vol. 41, 28.05.2022, p. 88-94.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard score. / Huynh-Le, Minh-Phuong; Karunamuni, Roshan; Fan, Chun Chieh et al.
In: Prostate Cancer and Prostatic Diseases, Vol. 25, No. 4, 04.2022, p. 755-761.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Assessing the causal role of epigenetic clocks in the development of multiple cancers : a Mendelian randomization study. / Morales Berstein, Fernanda; McCartney, Daniel L; Lu, Ake T et al.
In: eLife, Vol. 11, e75374, 03.2022.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers : A mendelian randomization analysis. / Yarmolinsky, James; Díez-Obrero, Virginia; Richardson, Tom G et al.
In: PLOS Medicine, Vol. 19, No. 2, e1003897, 02.2022.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Circulating inflammatory cytokines and risk of five cancers : a Mendelian randomization analysis. / Bouras, Emmanouil; Karhunen, Ville; Gill, Dipender et al.
In: BMC Medicine, Vol. 20, No. 1, 3, 01.2022.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Dysbiotic microbes and how to find them : a review of microbiome profiling in prostate cancer. / Salachan, Paul Vinu; Sørensen, Karina Dalsgaard.
In: Journal of Experimental & Clinical Cancer Research, Vol. 41, No. 1, 31, 01.2022.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Review › Research › peer-review
Evaluation of Predictors of Biochemical Recurrence in Prostate Cancer Patients, as Detected by 68Ga-PSMA PET/CT. / Tranberg Christensen, Mads; Jochumsen, Mads Ryø; Klingenberg, Søren et al.
In: Diagnostics, Vol. 12, No. 1, 195, 01.2022.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Microbiota of the prostate tumor environment investigated by whole-transcriptome profiling. / Salachan, Paul Vinu; Rasmussen, Martin; Fredsøe, Jacob et al.
In: Genome Medicine, Vol. 14, 9, 01.2022.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
The relationship between lipoprotein A and other lipids with prostate cancer risk : A multivariable Mendelian randomisation study. / Ioannidou, Anna; Watts, Eleanor L; Perez-Cornago, Aurora et al.
In: PLOS Medicine, Vol. 19, No. 1, e1003859, 01.2022.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
The transcriptional landscape and biomarker potential of circular RNAs in prostate cancer. / Hansen, Emma Kirstine Bollmann; Fredsøe, Jacob Hesselvig; Okholm, Trine Line Hauge et al.
In: Genome Medicine, Vol. 14, No. 1, 8, 01.2022.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Independent validation of a pre-specified four-kallikrein marker model for prediction of adverse pathology and biochemical recurrence. / Rasmussen, Martin; Fredsøe, Jacob; Tin, Amy L. et al.
In: British Journal of Cancer, Vol. 126, No. 7, 2022, p. 1004-1009.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Risk stratification in men with a negative prostate biopsy : An interim analysis of a prospective cohort study. / Sandahl, Mads; Pedersen, Bodil Ginnerup; Ulhøi, Benedicte Parm et al.
In: BJU International, Vol. 128, No. 6, 12.2021, p. 702-712.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Immune cell analyses of the tumor microenvironment in prostate cancer highlight infiltrating regulatory T cells and macrophages as adverse prognostic factors. / Andersen, L B; Nørgaard, Maibritt; Rasmussen, M et al.
In: Journal of Pathology, Vol. 255, No. 2, 10.2021, p. 155-165.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancer. / Wang, Victoria; Geybels, Milan S; Jordahl, Kristina M et al.
In: The Prostate, Vol. 81, No. 10, 07.2021, p. 683-693.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer. / Karunamuni, Roshan A; Huynh-Le, Minh-Phuong; Fan, Chun C et al.
In: Prostate Cancer and Prostatic Diseases, Vol. 24, 06.2021, p. 532-541.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
High-throughput and automated acoustic trapping of extracellular vesicles to identify microRNAs with diagnostic potential for prostate cancer. / Ku, Anson; Fredsøe, Jacob Hesselvig; Sørensen, Karina Dalsgaard et al.
In: Frontiers in Oncology, Vol. 11, 631021, 03.2021.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
68Ga-PSMA PET/CT for primary lymph node and distant metastasis NM staging of high-risk prostate cancer. / Klingenberg, Søren; Jochumsen, Mads Ryø; Ulhøi, Benedicte Parm et al.
In: Journal of Nuclear Medicine, Vol. 62, No. 2, 02.2021, p. 214-220.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Polygenic hazard score is associated with prostate cancer in multi-ethnic populations. / Huynh-Le, Minh-Phuong; Fan, Chun Chieh; Karunamuni, Roshan et al.
In: Nature Communications, Vol. 12, No. 1, 1236, 02.2021.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
FRMD6 has tumor suppressor functions in prostate cancer. / Haldrup, Jakob; Strand, Siri H; Cieza-Borrella, Clara et al.
In: Oncogene, Vol. 40, No. 4, 01.2021, p. 763–776.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction. / Conti, David V; Darst, Burcu F; Moss, Lilit C et al.
In: Nature Genetics, Vol. 53, No. 1, 01.2021, p. 65-75.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
The CHEK2 Variant C.349A>G Is Associated with Prostate Cancer Risk and Carriers Share a Common Ancestor. / Brandão, Andreia; Paulo, Paula; Maia, Sofia et al.
In: Cancers, Vol. 12, No. 11, 11.2020.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
An integrative multi-omics analysis to identify candidate DNA methylation biomarkers related to prostate cancer risk. / Wu, Lang; Yang, Yaohua; Guo, Xingyi et al.
In: Nature Communications, Vol. 11, 3905, 08.2020.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Epigenetic Analysis of Circulating Tumor DNA in Localized and Metastatic Prostate Cancer : Evaluation of Clinical Biomarker Potential. / Bjerre, Marianne Trier; Nørgaard, Maibritt; Larsen, Ole Halfdan et al.
In: Cells, Vol. 9, No. 6, 1362, 06.2020.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
FcRn overexpression in human cancer drives albumin recycling and cell growth : a mechanistic basis for exploitation in targeted albumin-drug designs. / Larsen, Maja Thim; Mandrup, Ole A; Schelde, Karen Kræmmer et al.
In: Journal of Controlled Release, Vol. 322, 06.2020, p. 53-63.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
A genetic risk assessment for prostate cancer influences patients’ risk perception and use of repeat PSA testing: a cross-sectional study in Danish general practice. / Fredsøe, Jacob Hesselvig; Kirkegaard, Pia; Edwards, Adrian et al.
In: British Journal of General Practice Open , 05.2020.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Appraising causal relationships of dietary, nutritional and physical-activity exposures with overall and aggressive prostate cancer : two-sample Mendelian-randomization study based on 79 148 prostate-cancer cases and 61 106 controls. / Kazmi, Nabila; Haycock, Philip; Tsilidis, Konstantinos et al.
In: International Journal of Epidemiology, Vol. 49, No. 2, 04.2020, p. 587-596.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Genomic analysis of male puberty timing highlights shared genetic basis with hair colour and lifespan. / Hollis, Ben; Day, Felix R; Busch, Alexander S et al.
In: Nature Communications, Vol. 11, No. 1, 1536, 24.03.2020.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
A Nordic initiative for a more personal and accurate diagnostic pathway for prostate cancer. / Kjosavik, Svein R; Sørensen, Karina Dalsgaard; Hotakainen, Kristina et al.
In: Scandinavian Journal of Primary Health Care, Vol. 38, No. 3, 2020, p. 249-250.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Editorial › peer-review
Germline genetic variation in prostate susceptibility does not predict outcomes in the chemoprevention trials PCPT and SELECT. / Ahmed, Mahbubl; Goh, Chee; Saunders, Edward et al.
In: Prostate Cancer and Prostatic Diseases, Vol. 23, No. 2, 2020, p. 333-342.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Profiling of Circulating microRNAs in Prostate Cancer Reveals Diagnostic Biomarker Potential. / Fredsøe, Jacob; Rasmussen, Anne K. I.; Mouritzen, Peter et al.
In: Diagnostics, Vol. 10, No. 4, 188, 2020.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
The effect of assessing genetic risk of prostate cancer on the use of PSA tests in primary care : A cluster randomized controlled trial. / Fredsøe, Jacob; Koetsenruijter, Jan; Vedsted, Peter et al.
In: PLOS Medicine, Vol. 17, No. 2, 2020, p. e1003033.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Validation of the four-miRNA biomarker panel MiCaP for prediction of long-term prostate cancer outcome. / Strand, Siri H.; Schmidt, Linnéa; Weiss, Simone et al.
In: Scientific Reports, Vol. 10, No. 1, 10704, 2020.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Association analyses identify 31 new risk loci for colorectal cancer susceptibility. / The PRACTICAL Consortium.
In: Nature Communications, Vol. 10, No. 1, 2154, 01.12.2019.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Elevated miR-615-3p Expression Predicts Adverse Clinical Outcome and Promotes Proliferation and Migration of Prostate Cancer Cells. / Laursen, Emma B; Fredsøe, Jacob; Schmidt, Linnéa et al.
In: The American Journal of Pathology, Vol. 189, No. 12, 12.2019, p. 2377-2388.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
A five-microRNA model (pCaP) for predicting prostate cancer aggressiveness using cell-free urine. / Fredsøe, Jacob; Rasmussen, Anne K I; Mouritzen, Peter et al.
In: International Journal of Cancer, Vol. 145, No. 9, 01.11.2019, p. 2558-2567.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Genetic predisposition to mosaic Y chromosome loss in blood. / Thompson, Deborah J; Genovese, Giulio; Halvardson, Jonatan et al.
In: Nature, Vol. 575, No. 7784, 11.2019, p. 652-657.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Epigenetic silencing of MEIS2 in prostate cancer recurrence. / Nørgaard, Maibritt; Haldrup, Christa; Bjerre, Marianne Trier et al.
In: Clinical Epigenetics, Vol. 11, No. 1, 147, 22.10.2019, p. 147.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Circulating vitamin D concentrations and risk of breast and prostate cancer : a Mendelian randomization study. / Jiang, Xia; Dimou, Niki L; Al-Dabhani, Kawthar et al.
In: International Journal of Epidemiology, Vol. 48, No. 5, 01.10.2019, p. 1416-1424.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Epigenetics of Urological Cancers. / Schulz, Wolfgang A.; Sørensen, Karina D.
In: International Journal of Molecular Sciences , Vol. 20, No. 19, 4775, 10.2019.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Editorial › peer-review
Analysis of Over 140,000 European Descendants Identifies Genetically Predicted Blood Protein Biomarkers Associated with Prostate Cancer Risk. / Wu, Lang; Shu, Xiang; Bao, Jiandong et al.
In: Cancer Research, Vol. 79, No. 18, 15.09.2019, p. 4592-4598.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Identification of Novel Susceptibility Loci and Genes for Prostate Cancer Risk : A Transcriptome-Wide Association Study in Over 140,000 European Descendants. / Wu, Lang; Wang, Jifeng; Cai, Qiuyin et al.
In: Cancer Research, Vol. 79, No. 13, 01.07.2019, p. 3192-3204.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Runs of homozygosity and testicular cancer risk. / Loveday, C; Sud, A; Litchfield, K et al.
In: Andrology, Vol. 7, No. 4, 07.2019, p. 555-564.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
The role of plasma microseminoprotein-beta in prostate cancer : an observational nested case-control and Mendelian randomization study in the European prospective investigation into cancer and nutrition. / Smith Byrne, K; Appleby, P N; Key, T J et al.
In: Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 30, No. 6, 01.06.2019, p. 983-989.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Investigating the effects of lycopene and green tea on the metabolome of men at risk of prostate cancer : The ProDiet randomised controlled trial. / Beynon, Rhona A; Richmond, Rebecca C; Santos Ferreira, Diana L et al.
In: International Journal of Cancer, Vol. 144, No. 8, 15.04.2019, p. 1918-1928.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Independent Validation of a Diagnostic Noninvasive 3-MicroRNA Ratio Model (uCaP) for Prostate Cancer in Cell-Free Urine. / Fredsøe, Jacob; Rasmussen, Anne K I; Laursen, Emma B et al.
In: Clinical Chemistry, Vol. 65, No. 4, 04.2019, p. 540-548.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Aberrant DOCK2, GRASP, HIF3A and PKFP Hypermethylation has Potential as a Prognostic Biomarker for Prostate Cancer. / Bjerre, Marianne T.; Strand, Siri H.; Nørgaard, Maibritt et al.
In: International Journal of Molecular Sciences , Vol. 20, No. 5, 1173, 03.2019.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Circulating Metabolic Biomarkers of Screen-Detected Prostate Cancer in the ProtecT Study. / Adams, Charleen D; Richmond, Rebecca; Ferreira, Diana L Santos et al.
In: Cancer Epidemiology, Biomarkers & Prevention, Vol. 28, No. 1, 01.2019, p. 208-216.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Prostate Cancer Risk-Associated Single-Nucleotide Polymorphism Affects Prostate-Specific Antigen Glycosylation and Its Function. / Srinivasan, Srilakshmi; Stephens, Carson; Wilson, Emily et al.
In: Clinical Chemistry, Vol. 65, No. 1, 01.2019, p. e1-e9.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
5hmC Level Predicts Biochemical Failure Following Radical Prostatectomy in Prostate Cancer Patients with ERG Negative Tumors. / Kristensen, Gitte; Strand, Siri; Røder, Martin Andreas et al.
In: International Journal of Molecular Sciences , Vol. 20, No. 5, 1025, 2019.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
A novel combined miRNA and methylation marker panel (miMe) for prediction of prostate cancer outcome after radical prostatectomy. / Strand, Siri H; Bavafaye-Haghighi, Elham; Kristensen, Helle et al.
In: International Journal of Cancer, Vol. 145, No. 12, 2019, p. 3445-3452.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Shared heritability and functional enrichment across six solid cancers. / Jiang, Xia; Finucane, Hilary K; Schumacher, Fredrick R et al.
In: Nature Communications, Vol. 10, No. 1, 431, 2019.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants. / Dadaev, Tokhir; Saunders, Edward J; Newcombe, Paul J et al.
In: Nature Communications, Vol. 9, No. 1, 2256, 01.12.2018.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Large-scale transcriptome-wide association study identifies new prostate cancer risk regions. / The PRACTICAL Consortium.
In: Nature Communications, Vol. 9, No. 1, 4079, 01.12.2018.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Diagnostic and Prognostic MicroRNA Biomarkers for Prostate Cancer in Cell-free Urine. / Fredsøe, Jacob; Rasmussen, Anne K I; Thomsen, Anni R et al.
In: European Urology Focus, Vol. 4, No. 6, 12.2018, p. 825-833.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Exploring the transcriptome of hormone-naive multifocal prostate cancer and matched lymph node metastases. / Schmidt, Linnéa; Møller, Mia; Haldrup, Christa et al.
In: British Journal of Cancer, Vol. 119, No. 12, 12.2018, p. 1527-1537.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Germline variation at 8q24 and prostate cancer risk in men of European ancestry. / PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium.
In: Nature Communications, Vol. 9, No. 1, 05.11.2018.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Picomolar sensitive and SNP-selective "Off-On" hairpin genosensor based on structure-tunable redox indicator signals. / Kékedy-Nagy, László; Sørensen, Karina Dalsgaard; Ferapontova, Elena E.
In: Biosensors and Bioelectronics, Vol. 117, 15.10.2018, p. 444-449.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma. / Went, Molly; Sud, Amit; Försti, Asta et al.
In: Nature Communications, Vol. 9, No. 1, 3707, 13.09.2018, p. 3707.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Training and validation of a novel 4-miRNA ratio model (MiCaP) for prediction of postoperative outcome in prostate cancer patients. / Schmidt, L.; Fredsøe, J.; Kristensen, H. et al.
In: Annals of Oncology, Vol. 29, No. 9, 01.09.2018, p. 2003-2009.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Dysregulation and prognostic potential of 5-methylcytosine (5mC), 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) levels in prostate cancer. / Storebjerg, Tine Maj; Strand, Siri H; Høyer, Søren et al.
In: Clinical Epigenetics, Vol. 10, No. 1, 105, 07.08.2018, p. 105.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. / Schumacher, Fredrick R; Al Olama, Ali Amin; Berndt, Sonja I et al.
In: Nature Genetics, Vol. 50, No. 7, 07.2018, p. 928-936.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Letter › peer-review
Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia. / Vijayakrishnan, Jayaram; Studd, James; Broderick, Peter et al.
In: Nature Communications, Vol. 9, No. 1, 09.04.2018, p. 1340.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Biomarker potential of ST6GALNAC3 and ZNF660 promoter hypermethylation in prostate cancer tissue and liquid biopsies. / Haldrup, Christa; Pedersen, Anne L; Øgaard, Nadia et al.
In: Molecular Oncology, Vol. 12, No. 4, 04.2018, p. 545-560.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Perceptions about screening for prostate cancer using genetic lifetime risk assessment: a qualitative study. / Kirkegaard, Pia; Edwards, Adrian; Nielsen, Trine Laura Overgaard et al.
In: B M C Family Practice, Vol. 19, No. 1, 32, 17.02.2018.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility. / The PRACTICAL Consortium.
In: Nature Communications, Vol. 8, No. 1, 1892, 01.12.2017.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Comprehensive Evaluation of TFF3 Promoter Hypomethylation and Molecular Biomarker Potential for Prostate Cancer Diagnosis and Prognosis. / Nørgaard, Maibritt; Haldrup, Christa; Storebjerg, Tine Maj et al.
In: International Journal of Molecular Sciences (Online), Vol. 18, No. 9, 20.09.2017.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
An Optimized Shotgun Strategy for the Rapid Generation of Comprehensive Human Proteomes. / Bekker-Jensen, Dorte B; Kelstrup, Christian D; Batth, Tanveer S et al.
In: Cell Systems, Vol. 4, No. 6, 28.06.2017, p. 587-599.e4.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
miRNAs associated with prostate cancer risk and progression. / Luu, Hung N; Lin, Hui-Yi; Sørensen, Karina Dalsgaard et al.
In: B M C Urology, Vol. 17, No. 1, 20.03.2017, p. 18.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Review › Research › peer-review
epiG : statistical inference and profiling of DNA methylation from whole-genome bisulfite sequencing data. / Vincent, Martin; Mundbjerg, Kamilla; Skou Pedersen, Jakob et al.
In: Genome Biology (Online Edition), Vol. 18, No. 1, 21.02.2017, p. 38.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Identifying aggressive prostate cancer foci using a DNA methylation classifier. / Mundbjerg, Kamilla; Chopra, Sameer; Alemozaffar, Mehrdad et al.
In: Genome Biology, Vol. 18, No. 1, 12.01.2017, p. 3.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Heterogeneous patterns of DNA methylation-based field effects in histologically normal prostate tissue from cancer patients. / Møller, Mia; Strand, Siri; Mundbjerg, Kamilla et al.
In: Scientific Reports, Vol. 7, 40636, 2017.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
RHCG and TCAF1 promoter hypermethylation predicts biochemical recurrence in prostate cancer patients treated by radical prostatectomy. / Strand, Siri; Switnicki, Michal; Moller, Mia et al.
In: OncoTarget, Vol. 8, No. 4, 2017, p. 5774-5788.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer. / Ross-Adams, Helen; Ball, Stephen J.; Lawrenson, Kate et al.
In: OncoTarget, Vol. 7, No. 46, 15.11.2016, p. 74734-74746.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Prevalence of the HOXB13 G84E mutation in Danish men treated by radical prostatectomy and correlations with prostate cancer risk and aggressiveness. / Storebjerg, Tine Maj; Høyer, Søren; Kirkegaard, Pia et al.
In: B J U International (Online), Vol. 118, No. 4, 01.10.2016, p. 646-653.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Prevalence of the HOXB13 G84E mutation in Danish men undergoing radical prostatectomy and its correlations with prostate cancer risk and aggressiveness. / the LuCamp Study Group.
In: BJU International, Vol. 118, No. 4, 01.10.2016, p. 646-653.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
The Potential of MicroRNAs as Prostate Cancer Biomarkers. / Fabris, Linda; Ceder, Yvonne; Chinnaiyan, Arul M et al.
In: European Urology, Vol. 70, No. 2, 21, 01.08.2016, p. 312-322.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Large-scale evaluation of SLC18A2 in prostate cancer reveals diagnostic and prognostic biomarker potential at three molecular levels. / Haldrup, Christa; Lynnerup, Anne-Sofie; Storebjerg, Tine Maj et al.
In: Molecular Oncology, Vol. 10, No. 6, 8, 01.06.2016, p. 825-837.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Novel diagnostic and prognostic classifiers for prostate cancer identified by genome-wide microRNA profiling. / Kristensen, Helle; Thomsen, Anni R; Haldrup, Christa et al.
In: OncoTarget, Vol. 7, No. 21, 24.05.2016, p. 30760-30771.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
PINCAGE : Probabilistic integration of cancer genomics data for perturbed gene identification and sample classification. / Świtnicki, Michał P; Rasmussen, Malene Juul; Madsen, Tobias et al.
In: Bioinformatics, Vol. 32, No. 9, 06.01.2016, p. 1353-1365.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Bivalent Regions of Cytosine Methylation and H3K27 Acetylation Suggest an Active Role for DNA Methylation at Enhancers. / Charlet, Jessica; Duymich, Christopher E; Lay, Fides D et al.
In: Molecular Cell, Vol. 62, No. 3, 2016, p. 422-31.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
BS-SNPer : SNP calling in Bisulfite-seq data. / Gao, Shengjie; Zou, Dan; Mao, Likai et al.
In: Bioinformatics (Online), Vol. 31, 28.08.2015.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci. / Amin Al Olama, Ali; Benlloch, Sara; Antoniou, Antonis C et al.
In: Cancer Epidemiology, Biomarkers & Prevention, Vol. 24, No. 7, 02.04.2015, p. 1121-1129.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Expression profiling of prostate cancer tissue delineates genes associated with recurrence after prostatectomy. / Mortensen, Martin Mørck; Høyer, Søren; Lynnerup, Anne-Sophie et al.
In: Scientific Reports, Vol. 5, 2015, p. 16018.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
High levels of 5-hydroxymethylcytosine (5hmC) is an adverse predictor of biochemical recurrence after prostatectomy in ERG-negative prostate cancer. / Strand, Siri; Hoyer, Soren; Lynnerup, Anne-Sofie et al.
In: Clinical Epigenetics (Print), Vol. 7, 2015, p. 111.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
SMAP : a streamlined methylation analysis pipeline for bisulfite sequencing. / Gao, Shengjie; Zou, Dan; Mao, Likai et al.
In: GigaScience, Vol. 4, 2015, p. 29.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
A dual program for translation regulation in cellular proliferation and differentiation. / Gingold, Hila; Tehler, Disa; Christoffersen, Nanna R et al.
In: Cell, Vol. 158, No. 6, 11.09.2014, p. 1281-92.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Next-generation sequencing of RNA and DNA isolated from paired fresh-frozen and formalin-fixed paraffin-embedded samples of human cancer and normal tissue. / Hedegaard, Jakob; Thorsen, Kasper; Lund, Mette Katrine et al.
In: PLOS ONE, Vol. 9, No. 5, 30.05.2014, p. e98187.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Hypermethylation of the GABRE~miR-452~miR-224 Promoter in Prostate Cancer Predicts Biochemical Recurrence after Radical Prostatectomy. / Kristensen, Helle; Haldrup, Christa; Strand, Siri et al.
In: Clinical Cancer Research, Vol. 20, No. 8, 15.04.2014, p. 2169-81.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
High miR-449b expression in prostate cancer is associated with biochemical recurrence after radical prostatectomy. / Mortensen, Martin Mørck; Høyer, Søren; Orntoft, Torben Falck et al.
In: B M C Cancer, Vol. 14, 2014, p. 859.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Profiling of circulating microRNAs for prostate cancer biomarker discovery. / Haldrup, Christa; Kosaka, Nobuyoshi; Ochiya, Takahiro et al.
In: Drug Delivery and Translational Research, Vol. 4, No. 1, 2014, p. 19-30.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Prognostic DNA methylation markers for prostate cancer. / Strand, Siri H; Orntoft, Torben F; Sorensen, Karina D.
In: International Journal of Molecular Sciences (Online), Vol. 15, No. 9, 2014, p. 16544-76.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review